The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM
…, Y Hamaguchi, M Fujimoto, Y Ishimatsu… - …, 2012 - academic.oup.com
Objective. Interstitial lung disease (ILD), especially rapidly progressive ILD (RPILD), is a
major poor prognostic factor in patients with DM. We investigated the association of anti-…
major poor prognostic factor in patients with DM. We investigated the association of anti-…
Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis
…, S Hara, T Kakugawa, S Nakayama, Y Ishimatsu… - Chest, 2009 - Elsevier
Background Interstitial lung disease (ILD) associated with clinically amyopathic
dermatomyositis (CADM) is a potentially fatal condition in which the clinical features are not well …
dermatomyositis (CADM) is a potentially fatal condition in which the clinical features are not well …
[HTML][HTML] Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells
K Hisatomi, H Mukae, N Sakamoto, Y Ishimatsu… - BMC Pulmonary …, 2012 - Springer
Background Pirfenidone is a novel anti-fibrotic and anti-inflammatory agent that inhibits the
progression of fibrosis in animal models and in patients with idiopathic pulmonary fibrosis (…
progression of fibrosis in animal models and in patients with idiopathic pulmonary fibrosis (…
Pattern of lung cancer in Turkey, 1994–1998
…, H Mukae, T Iwashita, H Kaida, H Ishii, Y Ishimatsu… - Respiration, 2002 - karger.com
Background: Lung cancer is the most common neoplasm in Turkey, but there is not enough
data on the characteristics of this mortal illness in our country. Objectives and Methods: The …
data on the characteristics of this mortal illness in our country. Objectives and Methods: The …
[HTML][HTML] Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis
…, H Ishii, T Imanaga, T Harada, Y Ishimatsu… - Respiratory …, 2014 - Springer
Background Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is associated with
high mortality. However, few studies have so far reviewed analyses of autopsy findings in …
high mortality. However, few studies have so far reviewed analyses of autopsy findings in …
[HTML][HTML] S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis
A Hara, N Sakamoto, Y Ishimatsu, T Kakugawa… - Respiratory …, 2012 - Elsevier
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive
fibrosing interstitial pneumonia of unknown cause, and the prognosis remains poor. On the …
fibrosing interstitial pneumonia of unknown cause, and the prognosis remains poor. On the …
A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab
…, A Kawakami, N Sakamoto, Y Ishimatsu… - Rheumatology …, 2012 - Springer
A 68-year-old man, who was a patient with established rheumatoid arthritis (RA) with RA-associated
interstitial lung disease (RA-ILD) and pulmonary emphysema, began taking …
interstitial lung disease (RA-ILD) and pulmonary emphysema, began taking …
Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis
…, T Kakugawa, N Sakamoto, Y Ishimatsu… - Modern …, 2015 - academic.oup.com
Objective. We have tried to clarify the clinical importance of the measurement of serum type-I
interferon (IFN) in patients with anti-melanoma differentiation-associated gene 5 Ab (MDA5 …
interferon (IFN) in patients with anti-melanoma differentiation-associated gene 5 Ab (MDA5 …
Effect of long‐term treatment with corticosteroids on skeletal muscle strength, functional exercise capacity and health status in patients with interstitial lung disease
M Hanada, N Sakamoto, Y Ishimatsu… - …, 2016 - Wiley Online Library
Background and objective Corticosteroids are occasionally used in the treatment of ILD.
Chronic corticosteroid administration induces skeletal muscle weakness. However, it is unclear …
Chronic corticosteroid administration induces skeletal muscle weakness. However, it is unclear …
[HTML][HTML] Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis
…, A Hara, K Oda, H Ishimoto, K Yatera, Y Ishimatsu… - Respiratory …, 2016 - Springer
Background Acute exacerbations of idiopathic pulmonary fibrosis are major causes of
morbidity and mortality among patients with idiopathic pulmonary fibrosis. However, acute …
morbidity and mortality among patients with idiopathic pulmonary fibrosis. However, acute …